PT Industri Jamu dan Farmasi Sido Muncul Tbk operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Industri Jamu dan Farmasi Sido Muncul Tbk with three other
pharmaceutical manufacturers in Asia:
J B Chemicals and Pharmaceuticals Ltd
sales of 16.32 billion Indian Rupees [US$214.98 million]
of which 100%
JCR Pharmaceuticals Co., Ltd.
(23.16 billion Japanese Yen [US$215.16 million]
of which 99%
was Pharmaceutical Business), and
Huaren Pharmaceutical Co Ltd
based in CHINA
(1.46 billion Chinese Renmimbi [US$205.04 million]
of which 91%
was Medicine Industry).
PT Industri Jamu dan Farmasi Sido Muncul Tbk reported sales of 3.07 trillion Indonesian Rupiahs (US$208.59 million)
December of 2019.
increase of 11.0%
versus 2018, when the company's sales were 2.76 trillion Indonesian Rupiahs .
Sales at PT Industri Jamu dan Farmasi Sido Muncul Tbk have increased during each of the previous five years
(and since 2014, sales have increased a total of 40%).
Sales of Pharmacy saw an increase
17.0% in 2019, from
100.18 billion Indonesian Rupiahs to 117.25 billion Indonesian Rupiahs .